Discover 1,803 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,803
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
for
Endometrial Adenocarcinoma,
Location: Durham NC, Raleigh NC, Charlottesville VA, Richmond VA,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT05112601
Phase2, Recruiting
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
Selinexor and Backbone Treatments of Multiple Myeloma Patients
for
Multiple Myeloma
Location: Durham NC, Boston MA, Seattle WA
Sponsor: Karyopharm Therapeutics Inc
Sex: All
Age: 18+
Code: NCT02343042
Phase1, Phase2, Recruiting
Resources for Optimizing Outcomes in Toddlers on the Spectrum
for
Autism Spectrum Disorder
Location: Carrboro NC
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 1 - 70+
Code: NCT07086781
Recruiting
Phosphate in Acute Pancreatitis
for
Pancreatitis
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT07681050
Phase2, Recruiting
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections
for
Aortic Dissection
Location: Durham NC, Morgantown WV, Atlanta GA, Pittsburgh PA,
Sponsor: W.L.Gore & Associates
Sex: All
Age: 18+
Code: NCT06827990
Recruiting
Improving Needs Among Older Adults
for
Critical Illness, Palliative Care, Older Adults,
Location: Durham NC, Charleston SC, Birmingham AL, New York NY
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06588556
Recruiting
Safety of RSV Preventive Monoclonal Antibody
for
Fever, Adverse Event Following Immunisation
Location: Durham NC, Atlanta GA, Cincinnati OH, New York NY,
Sponsor: Duke University
Sex: All
Age: 0
Code: NCT07158814
Recruiting
Intent of Surgery for IPMN
for
Intraductal Papillary Mucinous Neoplasm
Location: Durham NC, Baltimore MD, New York NY, Boston MA,
Sponsor: NYU Langone Health
Sex: All
Age: 18+
Code: NCT07216521
Recruiting
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
for
Progressive Metastatic Castrate Resistant Prostate Cancer
Location: Durham NC, Atlanta GA, Cleveland OH, Denver CO,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT07206056
Phase1, Phase2, Recruiting
Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US
for
Hypertension, Dyslipidemias, Type 2 Diabetes, HIV-1-infection
Location: Durham NC, Charlotte NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT05129345
Recruiting
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
for
Heart Failure
Location: Durham NC, Falls Church VA, Camp Hill PA, Nashville TN,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 40 - 70+
Code: NCT06979362
Phase2, Recruiting
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
for
Renal Cell Carcinoma
Location: Durham NC, Pittsburgh PA, Nashville TN, New York NY,